ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19
Stock Information for BioSig Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.